Shaily Engineering Plastics Limited shares surged up to 3.5% after the company secured a ₹423 crore manufacturing and supply agreement with a leading domestic pharma player. The four-year contract for pen injectors enhances long-term business visibility and strengthens Shaily’s position in the fast-growing drug delivery segment.